News + Resources

Keep up with the latest

Featured

This Scientist Is Building Custom Gene-Editing Tools

This Scientist Is Building Custom Gene-Editing Tools

Epigenetic editors are a gentler form of gene editing

February 24, 2025

The Economist

Epigenetic editors are a gentler form of gene editing

February 24, 2025

Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024

November 25, 2024

Scribe Therapeutics Reports Preclinical Data Validating its CRISPR Genome Editing and Epigenome Modifying Technologies for Addressing Cardiometabolic Disease at American Heart Association (AHA) Scientific Sessions 2024

November 25, 2024

CRISPR 2.0, the Next Generation

June 21, 2024

Aspen Ideas: Health

CRISPR 2.0, the Next Generation

June 21, 2024

The Age of CRISPR: Engineering the Future of Genetic Medicine

February 23, 2024

TEDxBerkeley

The Age of CRISPR: Engineering the Future of Genetic Medicine

February 23, 2024

All Stories

All
News
Press Releases
News

Scribe Inks CRISPR Gene-Editing Deal with Prevail

May 19, 2023

Bloomberg

Read Now
News

Scribe signs another big pharma deal

May 19, 2023

Evaluate

Read Now
News

Lilly’s Prevail, Doudna’s Scribe Partner on Genetic Treatments for Neuro Diseases

May 17, 2023

BioSpace

Read Now
News

Scribe and Prevail partner for CRISPR-based genetic medicines

May 17, 2023

Pharmaceutical Technology

Read Now
News

Scribe and Prevail to accelerate CRISPR-based genetic medicines for neurological and neuromuscular diseases

May 17, 2023

Labiotech

Read Now
News

Biotech Scribe strikes gene editing deal with Lilly subsidiary

May 16, 2023

Biopharma Dive

Read Now
Press release

Scribe Therapeutics Expands In Vivo Collaboration with Sanofi to Second Target

January 3, 2024

Read Now
Press release

Scribe Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference

January 2, 2024

Read Now
Press release

Scribe Therapeutics Appoints Dr. Aarif Khakoo as Chief Scientific Officer and Head of Research and Development, and Dr. Maria Mirotsou as Vice President of Discovery Biology

December 20, 2023

Read Now
Press release

Scribe Therapeutics Expands Collaboration with Sanofi to Advance In Vivo Genetic Medicines for Sickle Cell and Other Genomic Diseases

July 17, 2023

Read Now
Press release

Scribe Therapeutics to Participate in Upcoming Investor Conferences in May and June

May 22, 2023

Read Now
Press release

Scribe Therapeutics Presents Data on its X-Editing Technologies at 2023 American Society of Gene and Cell Therapy (ASGCT) Annual Meeting

May 19, 2023

Read Now

Publications and presentations